協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/08/12 | 2,045 | 2,060 | 1,998 | 2,026 | +13 | +0.6% | 1,377,000 |
| 2015/08/11 | 2,044 | 2,044 | 1,989 | 2,013 | -6 | -0.3% | 1,468,000 |
| 2015/08/10 | 1,997 | 2,031 | 1,991 | 2,019 | +19 | +1% | 1,942,000 |
| 2015/08/07 | 2,032 | 2,032 | 1,977 | 2,000 | -40 | -2% | 1,863,000 |
| 2015/08/06 | 2,090 | 2,090 | 2,033 | 2,040 | -29 | -1.4% | 1,411,000 |
| 2015/08/05 | 2,070 | 2,091 | 2,052 | 2,069 | -3 | -0.1% | 1,469,000 |
| 2015/08/04 | 2,070 | 2,090 | 2,049 | 2,072 | +21 | +1% | 1,949,000 |
| 2015/08/03 | 2,000 | 2,059 | 1,993 | 2,051 | +33 | +1.6% | 1,419,000 |
| 2015/07/31 | 1,993 | 2,035 | 1,965 | 2,018 | +39 | +2% | 1,852,000 |
| 2015/07/30 | 1,960 | 1,989 | 1,949 | 1,979 | +4 | +0.2% | 1,606,000 |
| 2015/07/29 | 1,954 | 1,985 | 1,945 | 1,975 | +9 | +0.5% | 978,000 |
| 2015/07/28 | 1,921 | 1,987 | 1,912 | 1,966 | +33 | +1.7% | 1,575,000 |
| 2015/07/27 | 1,944 | 1,979 | 1,918 | 1,933 | +85 | +4.6% | 2,142,000 |
| 2015/07/24 | 1,847 | 1,862 | 1,840 | 1,848 | -6 | -0.3% | 689,000 |
| 2015/07/23 | 1,843 | 1,865 | 1,816 | 1,854 | +24 | +1.3% | 1,344,000 |
| 2015/07/22 | 1,848 | 1,865 | 1,825 | 1,830 | -17 | -0.9% | 957,000 |
| 2015/07/21 | 1,809 | 1,850 | 1,805 | 1,847 | +38 | +2.1% | 1,126,000 |
| 2015/07/17 | 1,775 | 1,818 | 1,774 | 1,809 | +47 | +2.7% | 1,806,000 |
| 2015/07/16 | 1,750 | 1,770 | 1,739 | 1,762 | +12 | +0.7% | 1,104,000 |
| 2015/07/15 | 1,746 | 1,775 | 1,731 | 1,750 | +4 | +0.2% | 1,430,000 |
| 2015/07/14 | 1,733 | 1,759 | 1,727 | 1,746 | +38 | +2.2% | 1,476,000 |
| 2015/07/13 | 1,677 | 1,712 | 1,677 | 1,708 | +49 | +3% | 1,986,000 |
| 2015/07/10 | 1,611 | 1,677 | 1,600 | 1,659 | +110 | +7.1% | 3,243,000 |
| 2015/07/09 | 1,520 | 1,553 | 1,497 | 1,549 | -9 | -0.6% | 1,383,000 |
| 2015/07/08 | 1,600 | 1,607 | 1,557 | 1,558 | -54 | -3.3% | 1,233,000 |
| 2015/07/07 | 1,639 | 1,651 | 1,605 | 1,612 | -26 | -1.6% | 1,666,000 |
| 2015/07/06 | 1,624 | 1,657 | 1,622 | 1,638 | -26 | -1.6% | 1,456,000 |
| 2015/07/03 | 1,639 | 1,673 | 1,639 | 1,664 | +36 | +2.2% | 855,000 |
| 2015/07/02 | 1,618 | 1,642 | 1,618 | 1,628 | +31 | +1.9% | 822,000 |
| 2015/07/01 | 1,617 | 1,617 | 1,577 | 1,597 | -4 | -0.2% | 1,150,000 |
| 2015/06/30 | 1,604 | 1,623 | 1,593 | 1,601 | -11 | -0.7% | 1,091,000 |
| 2015/06/29 | 1,646 | 1,646 | 1,608 | 1,612 | -57 | -3.4% | 1,291,000 |
| 2015/06/26 | 1,678 | 1,687 | 1,653 | 1,669 | -15 | -0.9% | 1,226,000 |
| 2015/06/25 | 1,700 | 1,706 | 1,682 | 1,684 | -27 | -1.6% | 1,061,000 |
| 2015/06/24 | 1,734 | 1,737 | 1,701 | 1,711 | +4 | +0.2% | 1,169,000 |
| 2015/06/23 | 1,684 | 1,709 | 1,671 | 1,707 | +35 | +2.1% | 1,156,000 |
| 2015/06/22 | 1,649 | 1,678 | 1,640 | 1,672 | +15 | +0.9% | 1,060,000 |
| 2015/06/19 | 1,690 | 1,703 | 1,649 | 1,657 | -11 | -0.7% | 1,750,000 |
| 2015/06/18 | 1,676 | 1,682 | 1,662 | 1,668 | -14 | -0.8% | 939,000 |
| 2015/06/17 | 1,687 | 1,687 | 1,662 | 1,682 | +5 | +0.3% | 790,000 |
| 2015/06/16 | 1,672 | 1,684 | 1,662 | 1,677 | -3 | -0.2% | 844,000 |
| 2015/06/15 | 1,689 | 1,689 | 1,662 | 1,680 | -10 | -0.6% | 787,000 |
| 2015/06/12 | 1,716 | 1,719 | 1,680 | 1,690 | ±0 | ±0% | 2,688,000 |
| 2015/06/11 | 1,658 | 1,692 | 1,654 | 1,690 | +43 | +2.6% | 1,359,000 |
| 2015/06/10 | 1,640 | 1,671 | 1,637 | 1,647 | +25 | +1.5% | 1,959,000 |
| 2015/06/09 | 1,630 | 1,648 | 1,621 | 1,622 | -22 | -1.3% | 1,827,000 |
| 2015/06/08 | 1,616 | 1,647 | 1,615 | 1,644 | +34 | +2.1% | 1,957,000 |
| 2015/06/05 | 1,596 | 1,612 | 1,583 | 1,610 | +28 | +1.8% | 1,583,000 |
| 2015/06/04 | 1,594 | 1,619 | 1,580 | 1,582 | +1 | +0.1% | 1,375,000 |
| 2015/06/03 | 1,570 | 1,586 | 1,565 | 1,581 | -7 | -0.4% | 1,081,000 |
2451～
2500
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
